Malignant Cervical Neoplasm — Trials

Malignant Cervical Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 506
Recruiting: 280
Ph III recruiting: 34
Growth YoY: −11.9%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.7%
Trials / 1,000 deaths: 121.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 101–102 of 102 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00673192	Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population	unknown	N/A	100	National Taiwan University HospitalOTHER	1	May 7, 2008	clinicaltrials
NCT00319462	Localization of Point A in Cervical Cancer	unknown	N/A	20	Mackay Memorial HospitalOTHER	1	Apr 19, 2007	clinicaltrials